A new report that surveyed patients with type 2 diabetes (T2D) and their caregivers found that living with the disease negatively impacts mental health, Dexcom announced in a release.1 The survey also found that continuous glucose monitors (CGM) make it easier to manage T2D and having access to the technology would have a positive impact.
The “State of Type 2 Report” from Dexcom was conducted in collaboration with market research company Censuswide. The survey included 250 patients living with T2D and 250 caregivers, such as family members. Over 350 health care professionals involved in the care of patients with T2D were also surveyed, including general practitioners, nurses, endocrinologists and dietitians.
Key Takeaways
- A Dexcom report shows that living with type 2 diabetes (T2D) significantly affects mental health, with 42% of survey respondents experiencing negative impacts, over 60% reporting anxiety, and 52% experiencing depression, mainly due to daily disease management challenges.
- Managing T2D on a daily basis is tough for many, with 63% finding it difficult. Challenges include less sleep, reluctance to inject insulin publicly, forgetting injections, and managing multiple medications.
- CGM technology could ease the burden of T2D management. 67% believe CGM could reduce stress, 57% think it could improve mental wellbeing, and 63% feel it could help them feel more like themselves.
“Our research reveals living with diabetes brings a range of challenges many don’t anticipate at the time of their Type 2 diagnosis,” authors of the report wrote. “Not only are there physical effects to contend with, but the need to continuously manage glucose levels often stops people from living their lives on their terms…People with diabetes and their caregivers recognize CGM technology would help alleviate some of the stress of having to manage their diabetes.”
READ MORE: CGM Becoming Standard of Care in Hospital Settings
There are over 500 million people living with diabetes worldwide and T2D accounts for around 96% of diagnosed cases.2 The prevalence of T2D is expected to continue to increase due to a rise in obesity. The condition is potentially reversible if managed successfully early in the course of disease, which is why different methods and strategies to help people living with T2D are crucial.
CGM has been one of the most beneficial advancements in the field of diabetes care. Although CGM use has been well established in type 1 diabetes, uptake among patients with T2D is still lacking, despite there being far more patients with T2D. Research has shown that CGM can help with glycemic control in patients with T2D, which results in fewer visits to the emergency room for hypoglycemia.3
In the report from Dexcom, 42% of respondents and caregivers said that living with type 2 diabetes has had a negative impact on their mental health. Over 60% said they or the person they care for suffers from and anxiety and 52% said they experience depression. One of the biggest reasons noted in the report contributing to the impacts on mental health was daily diabetes management, with 63% of respondents saying they find it difficult in some way.
Some of the reasons given for why respondents find it hard to manage diabetes on a daily basis included getting less sleep, not liking injecting insulin in public, finding it hard or forgetting to inject at times, and finding it difficult to manage all the necessary medications.
